FDA Warns of Transvaginal Mesh Complications
The U.S. Food and Drug Administration (FDA) has warned American health care providers and their patients about the very real risks associated with transvaginal mesh surgeries. In less than three years, TVM patients reported more than 1,000 adverse events related to their surgery. For the families of many patients, this indicates a systemic failure on the part of mesh manufacturers to appropriately design their product or warn patients about potential problems.
In some cases, these reports have indicated simply a failed surgery in which the patient didn’t experience the positive outcome she hoped to gain. In other situations, these adverse event reports suggest not only continued stress urinary incontinence, but also added complications, such as pain, infection and decreased quality of life.
Want to learn what the FDA’s report may mean for you? The attorneys at the Dallas law firm of Fears Nachawati are prepared to give you understandable advice and actionable choices. However you want to proceed, we can help with your next steps. For your free consultation, call us at 1.866.545.8364 or email email@example.com.